Largest health care biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 health care biotech companies ranked by total debt, at THB 1.85T, ahead of Gilead Sciences (THB 846.3B) and Biogen (THB 213.4B). Figures as of 20 Nov 2026, 02:02 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenTHB 1.85T
Median
THB 20B
Combined market value
THB 28.12T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
Health Care
Biotech
THB
Clear filters
Largest health care biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareTHB 1.85TTHB 8.06TTHB 14,893.55 1.14% down 32% up United States
2Gilead SciencesGILD · Health CareTHB 846.3BTHB 7.01TTHB 5,652.03 1.45% down 35% up United States
3BiogenBIIB · Health CareTHB 213.4BTHB 1.24TTHB 8,387.59 1.70% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareTHB 72.7BTHB 360BTHB 3,157.78 2.88% down 39% up United States
5QiagenQGEN · Health CareTHB 56.2BTHB 347.8BTHB 1,684.44 0.14% up 9% up Netherlands
6ModernaMRNA · Health CareTHB 20BTHB 2.74TTHB 6,765.26 1.29% up 780% up United States
7RepligenRGEN · Health CareTHB 18.4BTHB 369.5BTHB 5,779.64 1.38% down 12% up United States
8Bio-TechneTECH · Health CareTHB 6.8BTHB 387.6BTHB 2,467.44 0.07% down 24% up United States
9Adaptive BiotechnologiesADPT · Health CareTHB 4.5BTHB 154.1BTHB 952.02 1.44% down 74% up United States
10Scholar Rock HoldingSRRK · Health CareTHB 3.4BTHB 208.6BTHB 1,709.56 4.94% up 26% up United States
11CG OncologyCGON · Health CareTHB 101.8MTHB 248.3BTHB 2,779.69 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9400 THB). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which health care biotech companies rank first by total debt?

Amgen (THB 1.85T), Gilead Sciences (THB 846.3B) and Biogen (THB 213.4B) are the top three of the 11 health care biotech companies ranked by total debt as of 20 Nov 2026, 02:02 UTC.

How many health care biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 11 health care biotech companies ranked by total debt have a combined market value of THB 28.12T as of 20 Nov 2026, 02:02 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest health care biotech companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.